Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An announcement from Essex Bio-Technology ( (HK:1061) ) is now available.
Essex Bio-Technology Limited has announced a final ordinary cash dividend of HKD 0.06 per share for the financial year ending December 31, 2024. This announcement, dated March 26, 2025, highlights the company’s commitment to returning value to its shareholders, with the payment date set for June 9, 2025. The dividend reflects the company’s stable financial performance and may enhance its attractiveness to investors, reinforcing its position in the biotechnology sector.
More about Essex Bio-Technology
Essex Bio-Technology Limited operates in the biotechnology industry, focusing on the development and commercialization of biopharmaceutical products. The company’s primary products include treatments for ophthalmology and dermatology, with a market focus on innovative therapies for unmet medical needs.
YTD Price Performance: -3.74%
Average Trading Volume: 301,553
Technical Sentiment Signal: Sell
Current Market Cap: HK$1.63B
Find detailed analytics on 1061 stock on TipRanks’ Stock Analysis page.